×
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
S&P 500   3,785.38 (-0.88%)
DOW   30,775.43 (-0.82%)
QQQ   280.28 (-1.24%)
AAPL   136.72 (-1.80%)
MSFT   256.83 (-1.32%)
META   161.25 (-1.64%)
GOOGL   2,179.26 (-2.45%)
AMZN   106.21 (-2.49%)
TSLA   673.42 (-1.76%)
NVDA   151.59 (-2.46%)
NIO   21.72 (-0.64%)
BABA   113.68 (-2.03%)
AMD   76.47 (-1.95%)
MU   55.28 (-1.32%)
CGC   2.85 (-18.57%)
T   20.96 (+0.05%)
GE   63.67 (-0.03%)
F   11.13 (-3.39%)
DIS   94.40 (-1.31%)
AMC   13.55 (-0.73%)
PFE   52.43 (+2.93%)
PYPL   69.84 (-2.28%)
NFLX   174.87 (-1.96%)
OTCMKTS:GNGBY

Getinge AB (publ) Stock Forecast, Price & News

$23.15
+0.19 (+0.83%)
(As of 06/30/2022 03:48 PM ET)
Add
Compare
Today's Range
$22.75
$23.19
50-Day Range
$20.36
$36.58
52-Week Range
$19.93
$48.89
Volume
46,351 shs
Average Volume
33,966 shs
Market Capitalization
$5.88 billion
P/E Ratio
19.29
Dividend Yield
1.31%
Price Target
$41.32
30 days | 90 days | 365 days | Advanced Chart

Receive GNGBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

GNGBY Stock Forecast (MarketRank)

Overall MarketRank

2.42 out of 5 stars

Analyst Opinion: 3.1Community Rank: 4.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -
Getinge AB (publ) logo

About Getinge AB (publ) (OTCMKTS:GNGBY)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

GNGBY Stock News Headlines

Cheuvreux Lowers Getinge AB (publ) (OTCMKTS:GNGBY) to Hold
Getinge AB ADR
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GNGBY
CIK
N/A
Employees
10,700
Year Founded
N/A

Company Calendar

Last Earnings
4/26/2022
Ex-Dividend for 5/18 Dividend
4/27/2022
Dividend Payable
5/18/2022
Today
6/30/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$256.58
High Stock Price Forecast
$425.00
Low Stock Price Forecast
$41.32
Forecasted Upside/Downside
+78.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$346.18 million
Pretax Margin
14.99%

Debt

Sales & Book Value

Annual Sales
$3.15 billion
Cash Flow
$2.49 per share
Book Value
$11.55 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.88 billion
Optionable
Not Optionable
Beta
1.10














Getinge AB (publ) Frequently Asked Questions

Should I buy or sell Getinge AB (publ) stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Getinge AB (publ) in the last twelve months. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Getinge AB (publ) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNGBY, but not buy additional shares or sell existing shares.
View analyst ratings for Getinge AB (publ)
or view top-rated stocks.

What is Getinge AB (publ)'s stock price forecast for 2022?

8 equities research analysts have issued twelve-month target prices for Getinge AB (publ)'s shares. Their GNGBY stock forecasts range from $41.32 to $425.00. On average, they anticipate Getinge AB (publ)'s stock price to reach $256.58 in the next year. This suggests a possible upside of 1,008.3% from the stock's current price.
View analysts' price targets for Getinge AB (publ)
or view top-rated stocks among Wall Street analysts.

How has Getinge AB (publ)'s stock performed in 2022?

Getinge AB (publ)'s stock was trading at $43.73 at the beginning of the year. Since then, GNGBY stock has decreased by 47.1% and is now trading at $23.15.
View the best growth stocks for 2022 here
.

Are investors shorting Getinge AB (publ)?

Getinge AB (publ) saw a increase in short interest in May. As of May 31st, there was short interest totaling 4,900 shares, an increase of 40.0% from the May 15th total of 3,500 shares. Based on an average daily volume of 52,600 shares, the short-interest ratio is presently 0.1 days.
View Getinge AB (publ)'s Short Interest
.

How were Getinge AB (publ)'s earnings last quarter?

Getinge AB (publ) (OTCMKTS:GNGBY) posted its quarterly earnings data on Tuesday, April, 26th. The company reported $0.23 earnings per share (EPS) for the quarter. The company earned $661.90 million during the quarter. Getinge AB (publ) had a trailing twelve-month return on equity of 14.02% and a net margin of 10.66%.
View Getinge AB (publ)'s earnings history
.

How often does Getinge AB (publ) pay dividends? What is the dividend yield for Getinge AB (publ)?

Getinge AB (publ) announced a dividend on Wednesday, April 20th. Investors of record on Thursday, April 28th will be paid a dividend of $0.3116 per share on Wednesday, May 18th. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Wednesday, April 27th.
View Getinge AB (publ)'s dividend history
.

Is Getinge AB (publ) a good dividend stock?

Getinge AB (publ)(OTCMKTS:GNGBY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.31%. The dividend payout ratio of Getinge AB (publ) is 25.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Getinge AB (publ) will have a dividend payout ratio of 18.63% next year. This indicates that Getinge AB (publ) will be able to sustain or increase its dividend.
View Getinge AB (publ)'s dividend history.

Who are Getinge AB (publ)'s key executives?

Getinge AB (publ)'s management team includes the following people:
  • Mr. Mattias Perjos M.Sc., CEO, Pres & Director (Age 50)
  • Mr. Lars Sandstrom M.Sc., Chief Financial Officer (Age 50)
  • Mr. Lars Mattsson, Head of Investor Relations
  • Ms. Anna Romberg MSc Econ, Exec. VP of Legal, Compliance & Governance (Age 43)
  • Ms. Jeanette Heden Carlsson, Exec. VP of Communications & Brand Management (Age 56)
  • Mr. Magnus Lundback Ph.D., Exec. VP of HR & Sustainability (Age 53)
  • Dr. Dieter Engel, Chief Technology Officer of Surgical Workflows
  • Mr. Carsten Blecker, Chief Commercial Officer (Age 56)
  • Ms. Lena Hagman B.Sc., Exec. VP of Quality & Regulatory Compliance (Age 57)
  • Mr. Stephane Le Roy, Pres of Surgical Workflows (Age 45)

What is Getinge AB (publ)'s stock symbol?

Getinge AB (publ) trades on the OTCMKTS under the ticker symbol "GNGBY."

How do I buy shares of Getinge AB (publ)?

Shares of GNGBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Getinge AB (publ)'s stock price today?

One share of GNGBY stock can currently be purchased for approximately $23.15.

How much money does Getinge AB (publ) make?

Getinge AB (publ) (OTCMKTS:GNGBY) has a market capitalization of $5.88 billion and generates $3.15 billion in revenue each year. The company earns $346.18 million in net income (profit) each year or $1.199990 on an earnings per share basis.

How many employees does Getinge AB (publ) have?

Getinge AB (publ) employs 10,700 workers across the globe.

How can I contact Getinge AB (publ)?

Getinge AB (publ)'s mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The official website for Getinge AB (publ) is www.getinge.com. The company can be reached via phone at (610) 335-0000, via email at [email protected], or via fax at 46-1-033-556-40.

This page (OTCMKTS:GNGBY) was last updated on 6/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.